/Investor DB

KAYA — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Uphealupheal.ioin𝕏Oct 2023

Upheal is an AI-native electronic health record (EHR) platform for therapists that generates clinical progress notes from sessions and includes scheduling, billing, telehealth, and compliance tools.

AI & Machine LearningDigital HealthMental HealthNew York, US

Juraj Chrappa(Founder)inKarolina Mrozkova(Director)Martin Horvath(Founder)

Board seatTomas Pacinda· per SEC Form D

Co-investorsCalm/Storm VCCredo VenturesHeadlineInovia CapitalKaya Ventures

Sensible Biotechnologiessensible.bioin𝕏Feb 2023

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in

BoardVishal Gulati(Director)Joel Schoppig(Director)

Co-investorsCivilization Ventures Management, LlcRecode VenturesTraun VenturesY CombinatorZAKA VCAmino Collective+11 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.